The TWEAK/Fn14/CD163 axis-implications for metabolic disease
Wiktoria Ratajczak1, Sarah D Atkinson1, Catriona Kelly2
1Northern Ireland Centre for Stratified Medicine, School of Biomedical Sciences, Ulster University, Altnagelvin Hospital Campus, C-TRIC Building Glenshane Road, Derry/Londonderry, Northern Ireland, UK.
Abstract:
TWEAK (tumor necrosis factor-like weak inducer of apoptosis) is a member of the TNF superfamily that controls a multitude of cellular events including proliferation, migration, differentiation, apoptosis, angiogenesis, and inflammation. TWEAK control of these events is via an expanding list of intracellular signalling pathways which include NF-κB, ERK/MAPK, Notch, EGFR and AP-1. Two receptors have been identified for TWEAK - Fn14, which targets the membrane bound form of TWEAK, and CD163, which scavenges the soluble form of TWEAK. TWEAK appears to elicit specific events based on the receptor to which it binds, tissue type in which it is expressed, specific extrinsic conditions, and the presence of other cytokines. TWEAK signalling is protective in healthy tissues, but in chronic inflammatory states become detrimental to the tissue. Consistent data show a role for the TWEAK/FN14/CD163 axis in metabolic disease, chronic autoimmune diseases, and acute ischaemic stroke. Low circulating concentrations of soluble TWEAK are predictive of poor cardiovascular outcomes in those with and without diabetes. This review details the current understanding of the TWEAK/Fn14/CD163 axis as one of the chief regulators of immune signalling and its cell-specific role in metabolic disease development and progression.
Insights
The TWEAK/Fn14/CD163 axis regulates immune signaling and impacts metabolic diseases. While protective in healthy tissues, this pathway becomes detrimental in chronic inflammation, affecting cardiovascular health.
Area of Science:
- Immunology
- Cell Biology
- Molecular Biology
Background:
- TWEAK (tumor necrosis factor-like weak inducer of apoptosis) is a TNF superfamily member regulating cellular events like proliferation, migration, and inflammation.
- TWEAK signaling involves pathways such as NF-κB, ERK/MAPK, Notch, EGFR, and AP-1.
- Two TWEAK receptors, Fn14 and CD163, mediate distinct cellular responses based on TWEAK form and binding context.
Purpose of the Study:
- To review the current understanding of the TWEAK/Fn14/CD163 axis.
- To elucidate the role of this axis in immune signaling and metabolic disease.
- To highlight the dual role of TWEAK signaling in health and disease.
Main Methods:
- Literature review of TWEAK/Fn14/CD163 axis functions.
- Analysis of TWEAK's involvement in various signaling pathways.
- Examination of TWEAK's role in different disease contexts.
Main Results:
- TWEAK signaling is context-dependent, varying with receptor, tissue, and cytokine milieu.
- The TWEAK/Fn14/CD163 axis is implicated in metabolic diseases, autoimmune disorders, and ischemic stroke.
- Low soluble TWEAK levels predict adverse cardiovascular outcomes, particularly in diabetic patients.
Conclusions:
- The TWEAK/Fn14/CD163 axis is a key regulator of immune responses.
- TWEAK signaling shifts from protective to detrimental in chronic inflammatory conditions.
- Understanding this axis is crucial for metabolic and cardiovascular disease progression.
More Related Videos
Related Concept Videos
Regulation of Metabolism
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Diabetes Mellitus: Type 2 and Gestational
Metabolic States of the Body: Fasting and Starvation
Overview of Fatty Acid Metabolism
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...


